Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-011298

Chief Financial Officer sold 318 shares at $10.22 ($3,250)

From the SEC's structured data for this filing

Trades in this filing

Trigilio Jeffrey · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-12 Sale : show line 1 in the form −318 $10.22 $3,250 87,685 D
Open-market sales · 318 sh · avg $10.22 · $3,250
Loading xslF345X04/doc4.xml…